medications similar to tirzepatide vs. Semaglutide: What's the Difference? How Tirzepatide Compares to Other

In clinical studies, participants saw up to 28.7 % average body-weight reduction in the latest Phase 3 trial the highest ever reported

This article outlines the key indicators to monitor, what to expect during the early weeks, and the clinical markers used to evaluate effectiveness alongside important safety information and the current regulatory status of retatrutide in the UK

En ensayos clnicos como SURMOUNT-1, las personas que tomaron la dosis ms alta (15 mg) perdieron entre un 20 % y un 22,5 % de su peso corporal durante 72 semanas

With a half-life of approximately six days, retatrutide supports once-weekly dosing